Prospective, Multi-Center Study Will Assess the Clinical Impact of Galleri® in addition to Currently Recommended Cancer Screenings in the Medicare Population
GRAIL, LLC, a healthcare company...
Mirum Pharmaceuticals, Inc. announced the presentation of a series of analyses demonstrating further benefit of LIVMARLI® (maralixibat) oral solution in patients with cholestatic pruritus...
New capability for Supply Chain Work Management enables seamless resolution of supply chain exceptions and ensures adherence to regulations like DSCSA.
TraceLink Inc., the leading...
The precision medicine technology is being used for patients with metastatic lung and bone tumors at City of Hope's Los Angeles location and could treat more...
The U.S. Food and Drug Administration approved Tyruko, the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of...
